Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05922657 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Registry to Gather Real World Use Data on the Cerene® Cryotherapy Device

Study acronym: Progress
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Site details revised at 1 of 2 sitesv7
  2. Primary and study completion dates: Dec 9, 2025 to Dec 31, 2027
    • Publications: details revised at 1 of 1 entry
    v6
  3. Study sites revised (2)
    • Publications: details revised at 1 of 1 entry
    v5
  4. Site contacts updated at 2 of 2 sitesv4
  5. Primary completion date: Jun 9, 2025 to Dec 9, 2025
    • Study sites: 1 to 2
    • Study completion date: Jul 9, 2025 to Dec 9, 2025
    v3
  6. Eligibility criteria expanded, about 5 wordsv2
  7. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Channel Medsystems, Inc., the manufacturer of the Cerene® Cryotherapy Device (Cerene), is initiating a prospective, observational registry, the Progress registry, to gather data during real world utilization of the Cerene® Cryotherapy Device (Cerene). The primary objective of this registry is to bridge the gap between clinical results and outcomes achieved and reported during the pivotal study of Cerene and those obtained during its real-world use.
Trial Details
NCT Number NCT05922657
Lead Sponsor Channel Medsystems
Conditions
(from sponsor)		 Heavy Menstrual Bleeding, Abnormal Uterine Bleeding, Menorrhagia
Related terms Menorrhagia, Metrorrhagia
Enrollment 300 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov